Plasma cell disorders, cryoglobulins and tumor immunity
16 min
- Tell MGUS from myeloma by M protein, marrow plasma cells, and myeloma-defining events
- Reject a cryoglobulin specimen that was not kept warm until separation
- Predict how tumor-antigen or HLA class I loss changes T-cell and NK-cell attack
Try first
Get the idea
Three categories from three findings
A monoclonal protein comes from one expanded plasma-cell or B-cell clone. Serum protein electrophoresis with serum free light chains detects it, and immunofixation types it.1 The International Myeloma Working Group then sorts the disorder by the M protein, the clonal marrow plasma cells and any myeloma-defining event.2
| Category | Pattern |
|---|---|
| Non-IgM MGUS | M protein below 3 g/dL, clonal marrow plasma cells below 10%, no defining event |
| Smoldering myeloma | M protein at least 3 g/dL (or urine M protein at least 500 mg/24 h), or clonal plasma cells 10% to below 60%, and no defining event |
| Multiple myeloma | Clonal plasma cells at least 10% or a biopsy-proven plasmacytoma, plus at least one defining event |
The defining events are the CRAB findings attributable to the clone: calcium above 11 mg/dL or more than 1 mg/dL above the upper reference limit, creatinine above 2 mg/dL or creatinine clearance below 40 mL/min, hemoglobin below 10 g/dL or more than 2 g/dL below the lower reference limit, and lytic bone lesions. Three biomarkers also count: clonal plasma cells at least 60%, an involved to uninvolved free-light-chain ratio at least 100 with the involved light chain at least 100 mg/L, and more than one focal MRI lesion of at least 5 mm.2
Cryoglobulins leave with a cold clot
Cryoglobulins precipitate in the cold and redissolve on warming. The specimen stays at 37 °C from collection through clotting and serum separation. A tube that cools early loses its precipitate into the clot, and warming the separated serum cannot bring it back. The laboratory rejects that specimen and asks for a new warm collection. A cryoglobulin can be monoclonal or mixed, so a positive result does not by itself show a plasma-cell neoplasm.3
What lets immunity see a tumor
Tumor cells can display neoantigens from mutations, viral proteins, and self proteins expressed out of place or in excess. CD8 T cells recognize these peptides on HLA class I. A tumor that loses HLA class I escapes much of the CD8 attack. The same loss removes an inhibitory signal for NK cells, which can then kill it. Antigen loss and checkpoint ligands such as PD-L1 are other escape routes.4,5
References
- Keren DF, Bocsi G, Billman BL, et al. Laboratory detection and initial diagnosis of monoclonal gammopathies. Arch Pathol Lab Med. 2022;146(5):575-590. doi:10.5858/arpa.2020-0794-CP
- Rajkumar SV, Dimopoulos MA, Palumbo A, et al. International Myeloma Working Group updated criteria for the diagnosis of multiple myeloma. Lancet Oncol. 2014;15(12):e538-e548. doi:10.1016/S1470-2045(14)70442-5
- Gulli F, Santini SA, Napodano C, et al. Cryoglobulin test and cryoglobulinemia hepatitis C-virus related. Mediterr J Hematol Infect Dis. 2017;9(1):e2017007. doi:10.4084/MJHID.2017.007
- Abbas AK, Lichtman AH, Pillai S, Henrickson S. Cellular and Molecular Immunology. 11th ed. Elsevier; 2025. Elsevier.
- Mittal D, Gubin MM, Schreiber RD, Smyth MJ. New insights into cancer immunoediting and its three component phases: elimination, equilibrium and escape. Curr Opin Immunol. 2014;27:16-25. doi:10.1016/j.coi.2014.01.004
Watch one
Rosalind Achebe, 71, a retired choir director, has back pain and fatigue. Her marrow biopsy report is back.
Which IMWG category do these results fit?
| Test | Result | Previous | Reference interval | Flag |
|---|---|---|---|---|
| M protein | 2.1 g/dL | Not detected | High | |
| Immunofixation | IgA lambda | No monoclonal band | ||
| Clonal marrow plasma cells | 18 % | High | ||
| Calcium | 11.8 mg/dL | 8.6–10.3 mg/dL | High | |
| Creatinine | 1.1 mg/dL | 0.5–1.1 mg/dL | ||
| Hemoglobin | 11.9 g/dL | 12.0–15.5 g/dL | Low |
Specimen: H 4, L 15, I 2. Serum, collected 07:50; marrow aspirate and biopsy the same week
- Confirm the clone. Immunofixation shows an IgA lambda M protein of 2.1 g/dL.
Classification starts from a confirmed, typed monoclonal protein.
- Read the marrow next. Clonal plasma cells at 18% are at least 10%, so the pattern is beyond MGUS.
The marrow percentage separates MGUS from the other two categories.
- Look for a CRAB finding. Calcium 11.8 mg/dL is above 11 mg/dL.
A defining event separates myeloma from smoldering myeloma.
- Check the other CRAB findings. Creatinine 1.1 mg/dL is under 2 mg/dL, and hemoglobin 11.9 g/dL is above 10 g/dL and within 2 g/dL of the lower limit.
Each CRAB criterion has its own cutoff, and a mild change does not qualify.
- Put the pattern together: at least 10% clonal plasma cells plus one defining event, attributable to the clone.
The clinical team decides whether the hypercalcemia comes from the clone.
Your turn
Use it
- Leopold Vance, 67, a retired jazz trumpeter, says his fingertips turn blue whenever he plays outdoors in winter.
- His provider orders serum protein studies and a cryoglobulin.
- The cryoglobulin tubes reach the laboratory in a courier cooler with ice packs, clotted and cold.
- His marrow biopsy later shows 7% clonal plasma cells. Calcium, creatinine, hemoglobin and bone imaging are unremarkable.
| Test | Result | Previous | Reference interval | Flag |
|---|---|---|---|---|
| M protein | 1.6 g/dL | Not detected | High | |
| Immunofixation | IgG kappa | No monoclonal band | ||
| Kappa/lambda free-light-chain ratio | 3.1 | 0.26–1.65 | High |
Specimen: H 3, L 11, I 1. Serum protein studies collected 10:20 and kept at room temperature
The clue that settled this case is the cold courier cooler. It made the first cryoglobulin unusable, and only a warm recollection could answer the question. His protein and marrow results fit MGUS, and the cryoglobulin found later does not change that category.
Results
- Tell MGUS from myeloma by M protein, marrow plasma cells, and myeloma-defining events
- Reject a cryoglobulin specimen that was not kept warm until separation
- Predict how tumor-antigen or HLA class I loss changes T-cell and NK-cell attack
To review
6 questions from this step will come back in Review.
Keep
Sources checked
The rest of this step
A short briefing, a demonstration at the bench, 3 practice problems and a short case.
A free account opens the rest and keeps your progress.